Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDA-2 in Lower/Intermediate-risk MDS (MD-CHINA)
NCT03335943Phase 4Unknown
- Sponsor
- Chinese Society of Hematology
- Start
- Dec 2017
- Primary completion
- Dec 2019
01
Overview
A Phase 4 trial of uroacitides in myelodysplastic syndrome (MDS), sponsored by Chinese Society of Hematology. Status: unknown.
02
Drugs
uroacitides
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT03335943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335943.